Shandong New Time Pharmaceutical Co., Ltd. is a subsidiary company of Lunan Pharmaceutical Group Corporation - a national key high and new technology enterprise. It was established in 2002 with 6 billion RMB investment which was self-raised by the Group Corporation. It is the largest, all complete, modernized, garden-like pharmaceutical production base in China. The company has state-level enterprise technology center and Postdoctoral Scientific Research Workstation. It also established scientific and technological relationship with many universities and scientific research institutions all over the country. Its scientific research strength is the antecedent of the company norm in the country. Shandong New Time Pharmaceutical covers 6 million square meters with more than 5000 employees. It mainly focuses on the developing and producing of the raw materials and dosages of the traditional Chinese medicine, chemical medicine and bio products. All its production area has passed the GMP authentication. There are scientific research area, bioengineering preparation area, chemical medicine producing area, traditional Chinese medicine producing area, synthetic pilot area, animals experiment center, environment protection center and office area, living and entertainment area. Its main product includes clavulanate potassium (300tons per year), 7-adca (3000tons per year), isoflurane (150tons per year), sevoflurane (260tons per year), faropenem sodium (10tons per year). among them the production capacity of clavulanate potassium and 7-adca is No. 1 in the world.
